LGD-4033 and Oxytocin Interaction

Monitor
Mechanism-based 51% confidence

LGD-4033 and Oxytocin have an interaction requiring monitoring for interaction with 51% confidence. Both LGD-4033 and Oxytocin can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). These compounds primarily affect different organ systems.

Compound Profiles

LGD-4033

Selective Androgen Receptor Modulator | Lean Mass

LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.

Half-life: ~24-36 hours Typical dose: 5-10 mg/day sarm, anabolic
androgen receptorepo receptor androgenicblood pressure raisingcarcinogenic riskestrogenic
View full profile

Oxytocin

Neurohypophysial Peptide | Social Bonding & Reproductive Hormone

Binds oxytocin receptors on uterine smooth muscle, triggering calcium influx and myometrial contractions. Stimulates prostaglandin release.

Half-life: 3-6 minutes Typical dose: Intranasal: 20-24 IU; Injectable: 10-40 IU; Sublingual: 50-100 IU hormonal, cognitive
dopamine receptorgabaoxytocin receptor blood pressure raisingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Brain
low

Shared Safety Flags

2x 2 compounds raise blood pressure (LGD-4033, Oxytocin). Monitor BP daily and consider cardiovascular support.
2x 2 compounds share the teratogenic safety flag (LGD-4033, Oxytocin). Monitor accordingly.

Frequently Asked Questions

Can I take LGD-4033 with Oxytocin?

Yes, but with caution. Both LGD-4033 and Oxytocin can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). Regular monitoring is advised.

Is LGD-4033 and Oxytocin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: blood pressure raising, teratogenic. Monitor accordingly.

What are the interactions between LGD-4033 and Oxytocin?

Both LGD-4033 and Oxytocin can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time LGD-4033 and Oxytocin?

LGD-4033 has a half-life of ~24-36 hours and Oxytocin has a half-life of 3-6 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: LGD-4033 vs Oxytocin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.